Journal of Shandong University (Health Sciences) ›› 2020, Vol. 1 ›› Issue (7): 32-37.doi: 10.6040/j.issn.1671-7554.0.2020.0096

Previous Articles     Next Articles

Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion

MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui   

  1. Medical College of Shihezi University, Shihezi 832000, Xinjiang Uygur Autonomous Region, China
  • Online:2020-07-20 Published:2020-07-10

Abstract: Objective To assess the relationship between miR-27b-3p and SMAD1 and to explore the effects of MiR-27b-3p on osteosarcoma cell proliferation, invasion and migration, so as to provide theoretical basis for targeted therapy of osteosarcoma. Methods Candidate target genes were predicted with bioinformatics methods. The targeting relationship between miR-27b-3p and SMAD1 was determined with dual luciferase report experiments. The SAOS-2 osteosarcoma cell line was selected with qRT-PCR. After SAOS-2 cells were transfected with miR-27b-3p, they were divided into 3 groups: miR-27b-3p inhibitor group, blank control group and negative control group. The effects of miR-27b-3p on SAOS-2 cells were detected with MTT, Transwell migration and invasion assay. The expression of SMAD1 after miR-27b-3p silencing was determined with Western blotting. Results Bioinformatics analysis showed there were binding sites of miR-27b-3p and SMAD1-UTR. Dual luciferase experiments showed the miR-27b-3p inhibitor group had higher expression of SMAD1 than the negative control group(P<0.05), and SMAD1 was the target gene of miR-27b-3p. MTT, Transwell migration and invasion assay showed the miR-27b-3p inhibitor group had reduced cell proliferation, migration and migration than the blank control group and negative control group(P<0.05). The miR-27b-3p inhibitor group had significantly lower protein expression of SMAD1 than negative control group(P<0.05). Conclusion miR-27b-3p can promote the proliferation, migration and invasion of osteosarcoma cells by regulating the expression of SMAD1, and may play a role as an oncogene in osteosarcoma cells.

Key words: Osteosarcoma, miR-27b-3p, SMAD1, Cell proliferation, Cell migration, Cell invasion

CLC Number: 

  • R738
[1] Ferrari S, Mercuri M, Bacci G. Comment on “Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols”[J]. J Clin Oncol, 2004, 17(3):131-137.
[2] Marina NM, Smeland S, Bielack SS, et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma(EURAMOS-1): an open-label, international, randomised controlled trial[J]. Lancet Oncol, 2016, 17(10):1396-1408.
[3] Luetke A, Meyers PA, Lewis I, et al. Osteosarcoma treatment-Where do we stand? A state of the art review[J]. Cancer Treat Rev, 2014, 40(4):523-532.
[4] Jones KB, Salah Z, Mare SD, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma[J]. Cancer Res, 2012, 72(7):1865-1877.
[5] Milowsky MI, Rumble RB, Booth CM, et al. Guideline on muscle-invasive and metastatic bladder cancer(European Association of Urology Guideline): American society of clinical oncology clinical practice guideline endorsement[J]. J Clin Oncol, 2016, 34(16):1945-1952.
[6] 李胜,王威,李建军,等.骨肉瘤靶向治疗研究进展[J].山东医药,2019,59(22):99-102.
[7] Fadaka AO, Klein A, Pretorius A. In silico identification of microRNAs as candidate colorectal cancer biomarkers[J]. Tumour Biol, 2019, 41(11):1-15.
[8] Li J, Zhou YY, Zhao L, et al. Effect of miR-145 on migration and invasion of ovarian cancer cells[J]. Acta Academiae Medicinae Sinicae, 2019, 41(5):581-588.
[9] Shi Y, Gong W, Lu L, et al. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells[J]. Braz J Med Biol Res, 2019, 52(11):8657.
[10] Zou J, Liao X, Zhang J, et al. Dysregulation of miR-195-5p/-218-5p/BIRC5 axis predicts a poor prognosis in patients with gastric cancer[J]. J Biol Regul Homeost Agents, 2019, 33(5):1377-1385.
[11] Gao YN, Ma YP. Expression analysis and epigenetics of microrna-28-5p in multiple myeloma[J].Experimental hematology, 2019, 27(5):1540-1547.
[12] Fang C, Zhu DX, Dong HJ, et al. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma[J]. Ann Hematol, 2012, 91(4):553-559.
[13] Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res, 2008, 18(10):997-1006.
[14] Cong C, Wang W, Tian J, et al. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma[J]. Cancer Biomark, 2018, 21(2):449.
[15] Jones KB, Salah Z, Del Mare S, et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma[J]. Cancer Res, 2012, 72(7):1865-1877.
[16] 阮水良, 韩晨阳, 官俏兵, 等. IL-9通过TGF-β/Smad通路诱导胃癌MKN-45细胞上皮-间充质转化[J]. 中国病理生理杂志, 2018, 34(10):28-33. RUAN Shuiliang, HAN Chenyang, GUAN Qiaobing, et al. IL-9 induces epithelial-mesenchymal transition of gastric cancer MKN-45 cells by TGF-β/Smad signaling pathway[J]. Chinese Journal of Pathophysiology, 2018,34(10): 28-53.
[17] 刘婷. N-糖基化抑制通过调控TGFβ/Smad通路对鼻咽癌细胞株恶性生物学行为的影响及其机制研究[D].广州:南方医科大学,2017.
[18] Xu TY, Chang YS, Jin J, et al. Bone morphogeneticprotein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck[J]. Arch Med Res, 2011, 42(2):128-137.
[19] Yang Y, Han L, He Z, et al. Advances in limb salvage treatment of osteosarcoma[J]. J Bone Oncol, 2018, 10(1):36-40.
[20] Chen S, Wang Q, Zhou XM, et al. MicroRNA-27b reverses docetaxel resistance of non-small cell lung carcinoma cells via targeting epithelial growth factor receptor[J]. Mol Med Rep, 2016, 14(1):949.
[21] Liu Y, Cai QY, Bao PP, et al. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes[J].Breast cancer Res, 2015, 152(1):183-191.
[22] Fukumoto I, Koshizuka K, Hanazawa T, et al. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma[J]. Int J Oncol, 2016, 49(3):1119.
[23] Kontomanolis E, Mitrakas A, Giatromanolaki A, et al. A pilot study on plasma levels of micro-RNAs involved in angiogenesis and vascular maturation in patients with breast cancer[J]. Med Oncol, 2017, 34(2):20.
[24] Zhang J, Yan YG, Wang C, et al. MicroRNAs in osteosarcoma[J]. Clin Chim Acta, 2015, 444(3):9-17.
[25] 张其川, 王素芳, 王云峰, 等. miRNA-27b在骨肉瘤中的表达及其临床意义[J].临床与病理杂志, 2017, 37(12):2633-2638. ZHANG Qichuan, WANG Sufang, WANG Yunfeng, et al. Expression and clinical significance of circulating microRNA-27b in patients with osteosarcoma[J]. Journal of Clinical and Pathology Research, 2017, 37(12):2633-2638.
[26] 姚霁航. miR-27b靶向调控CDH11促进宫颈癌细胞增殖、侵袭和EMT的相关研究[D].沈阳:中国医科大学,2017.
[27] Hongxin M, Lei Z, Jingna R, et al. Myricetin inhibits migration and invasion of hepatocellular carcinoma MHCC97H cell line by inhibiting the EMT process[J]. Oncol Lett, 2019, 18(6):6614-6620.
[28] Fernanda L, José TM, Castellón Enrique A, et al. Secreted protein acidic and rich in cysteine(SPARC)induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with high Gleason score in prostate cancer[J]. Asian J Androl, 2019, 21(6):557-564.
[29] 陈记军. 骨肉瘤患者血清中特异性microRNA表达谱的筛选及其临床意义的研究[D]. 南京:南京大学, 2013.
[30] Pacifici M. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses[J]. Matrix Biol, 2018, 10(1):71-72.
[31] Ramachandran A, Vizán P, Das D, et al. TGF-β uses a novel mode of receptor activation to phosphorylate SMAD1/5 and induce epithelial-to-mesenchymal transition[J]. Elife, 2018, 7:31756. doi: 10.7554/eLife.31756.
[32] Massague J. How cells read TGF-beta signals[J]. Nat Rev Mol Cell Biol, 2000, 1(3):169-178.
[33] Long Y, Zhu Y. Identification of FBXW7α-regulated genes in M1-polarized macrophages in colorectal cancer by RNA sequencing[J]. Saudi Med J, 2019, 40(8):766-773.
[34] Zhao X, Sun Q, Dou C, et al. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression[J]. Front Biosci(Landmark Ed), 2019, 24(1):1060-1070.
[35] Nokin MJ, Bellier J, Durieux F, et al. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer[J]. Breast Cancer Res, 2019, 21(1):11.
[1] ZHAO Ge, ZOU Cunhua, SONG Dongdong, ZHAO Shuping. Effects of tanshinone IIA on the proliferation and apoptosis of endometrial carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 53-58.
[2] WANG Zhengyang, XIA Yan, SHI Kaixuan, TAO Kun, WANG Xiaojie. Effects of Trametinib on PAX8 expression in ovarian cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 23-29.
[3] DU Tiantian, LI Juan, ZHAO Yinghui, DUAN Weili, WANG Jing, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression profiles of long non-coding RNA LINC02474 and effects on cell proliferation in colorectal cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(10): 57-67.
[4] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7-14.
[5] LI Xiaofeng, DU Xiaoyi, LIU Hainan, LIU Cheng, FAN Yidong. Berberines effects on the proliferation, apoptosis and DNA damage and repair of human renal cell carcinoma cells [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 54-59.
[6] HUANG Ping, ZHANG Kun, LI Fang, HUANG Guobao, YAN Bing,XIAO Dongjie, WANG Yunshan, LIU Hua. Comparative study on biological characteristics of mesenchymal stem cells from human umbilical cord and adipose [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 72-78.
[7] YANG Feilong, ZHOU Zunlin, REN Juchao, YAN Lei, LIU Hainan, ZHANG Wenhua, YU Nengwang, LI Dawei, XU Zhonghua. Effects and mechanisms of hepatoma-derived growth factor on the proliferation of prostate cancer cells [J]. Journal of Shandong University (Health Sciences), 2018, 56(1): 62-69.
[8] LU Heng, LIU Yanguo, LI Shuguang, CHEN Xiaokang, TIAN Qi, YI Cuihua, WANG Xiuwen. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 33-38.
[9] TU Yan, LI Zhenjiang, TANG Aiping, FEI Yan, LI Huihui, LI Jian, HE Wenfeng. RNAi-mediated silencing of CD147 inhibits the proliferation and invasion of leukemic cells SHI-1 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 1-5.
[10] XU Liangzhi1, CHEN Kunlun2. Inhibitory effect and its mechanism of emodin on the proliferation of human osteosarcoma cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 37-40.
[11] XU Min, ZHANG Xianghua, SUN Aili, NI Yihong, SUN Fudun, CHEN Shihong. High glucose induced RSC96 Schwann cells injury in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 44-48.
[12] ZHOU Jing, ZHENG Yabing, YAN Li, CHANG Xiaotian, ZHAO Shan, RONG Fengnian. Effects of estrogen and cis-platinum on PADI4 expression and cell proliferation in ovarian cancer cell line A2780 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 30-34.
[13] LI Ya-nan1, JIANG Ling1, HU Xiu-hui1, ZHANG Xiao-li1, LI jie2. Effects of potassium iodate and bisphenol A on the proliferation of  thyroid carcinoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 52-57.
[14] DAI Xin1, ZHENG Yan2, JIA Yan-fei2, XIAO Dong-jie2, TONG Shu-qing1, WANG Yun-shan2. Effects of DEC1 on proliferation of gastric cancer cells: an approach
through a eukaryotic over-expression vector
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 75-.
[15] SHEN Tao1, DAI Wei2, LI Yan3, XU Xiao-jun1, BA Gen1, FU Qin1. Expression and localization of SORBS1 in osteosarcoma cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 21-.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] WANG Huan-liang,SUN Bao-zhu,DU Hong-mei,ZHOU Chang-qing,ZHANG Li. Controlling the depth of propofol anesthesia using the bispectral indexand the systolic blood pressure[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(5): 471 -474 .
[2] ZHANG Ji-hui,WANG Hong-yi,LI Shu-yuan. Correlation between polymorphism of aldose reductase gene and retinopathy in type 2 diabetes mellitus[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(4): 399 -402 .
[3] YU Hui1,2, CHEN Shaohua1, ZHAO Jiajun2, GAO Ling3
. Effects of ethanol on glycogen content, GSK3β,
and PAMPK of L02 cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(04): 75 -78 .
[4] SONG Yong-hong,MA Chun-hong,LV Hong-juan,ZHU Chuan-fu,NIE Xiang-min,WANG Mei,LIU Yan,ZHANG Ping. HLA allele polymorphism in northern Hans of China[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(6): 546 -553 .
[5] ZENG Ji-ping,WANG Li-na,WANG Li-xiang,REN Xiao-hui,ZHANG Meng-ye,XIA Wen,CUI Xing. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(5): 467 -470 .
[6] SHU Ya,QI Feng. Jaw thrust device (JTD) on obesity patients for maintaining the airway patency during general anesthesia induction[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 1072 -1074 .
[7] HUANGQing,TIAN Hui,LI Lin,LIANG Fei,LIU Xi-xian. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(6): 556 -559 .
[8] ZHU Mei-jia,HAN Ju,WANG Xin-yi,LU Wei,WANG Ai-hua,GUAN Xin-hua,CAO Xia,CAO Bing-zhen. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(8): 834 -839 .
[9] HOU Xiao-yang,BU Pei-li,ZHANG Yun,FENG Jin-bo,LIU Chun-xi,LI Chuan-bao,HAO Ming-xiu. Peroxisome proliferatorsactivated receptor α play a critical role in the inhibition of myocardial fibrosis induced by AngⅡ in vitro[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(7): 665 -668 .
[10] ZHAO Zheng-bin1, XUE Shuang-lin2, ZHANG Li-ting1, LI Jun-feng1,ZHAO Rong-rong1, ZHOU Hai-lian3, CHEN Hong1. Effects of procyanidins on the proliferation of hepatic stellate cells and production of TIMP-1 induced by leptin[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(7): 46 .